Columbia University's Herbert Irving Comprehensive Cancer Center unites the major clinical, population, and basic cancer research efforts of Columbia University community and its affiliated hospitals in its mission to decrease the burden of cancer, through innovation and collaboration. The Cancer Center, initially funded in 1972 and designated comprehensive in 1979, provides the organizational infrastructure to promote interdisciplinary laboratory, clinical and population based cancer research. The Center's primary goal is to promote collaborative interactions leading to new approaches to cancer prevention, diagnosis, and treatment, especially for diverse population in the tri-state region (Northern New Jersey, Southeastern New York and Southwestern Connecticut) served by this Cancer Center. The Cancer Center includes four divisions (Laboratory Research, Clinical Research, Population Science and Core Facilities) comprising 11 programs. Support is requested for 13 shared core facilities that provide state-of-the-art expertise, technology and resources with considerable efficiency and cost savings, senior leadership (the director, 4 associate directors, and 7 additional executive committee members). Funds are also requested for Development, Planning and Evaluation, and Administration to support Center goals. The Cancer Center facilitates the efforts of its 276 members who generate a total of $140.9 million dollars in total research funding and $29.5 million in total NCI funding for 2002. The Cancer Center has experienced considerable growth over the current grant period with a 74% increase in NCI funding. During this funding period the Cancer Center has completed renovation of 6 floors of Irving Pavilion for out patients culminating in the opening of the Children's and Adolescents unit in 2001. The Cancer Center is currently programming a $130 million Irving Cancer Research Building scheduled to open in early 2004 which will contain 7 laboratory floors and 2 floors for animal care at approximately 11,000 net square feet per floor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013696-34
Application #
7127325
Study Section
Subcommittee G - Education (NCI)
Program Officer
Marino, Michael A
Project Start
1976-09-01
Project End
2008-06-30
Budget Start
2006-09-21
Budget End
2008-06-30
Support Year
34
Fiscal Year
2006
Total Cost
$1,841,557
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Ghorpade, Devram S; Ozcan, Lale; Zheng, Ze et al. (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673-677
Bianchetti, E; Bates, S J; Carroll, S L et al. (2018) Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep 8:17390
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa. Am J Ophthalmol 194:120-125
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439

Showing the most recent 10 out of 331 publications